Cetera Investment Advisers
CGTX icon

Cetera Investment Advisers’s Cognition Therapeutics CGTX Stock Holding History

Cetera Investment Advisers’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.8K Sell
19,850
-21,300
-52% -$25.2K ﹤0.01% 4844
2026
Q1 		$31.3K Hold
41,150
– – ﹤0.01% 4627
2025
Q4 		$55.6K Sell
41,150
-19,000
-32% -$30.8K ﹤0.01% 4492
2025
Q3 		$81.2K Buy
60,150
+49,800
+481% +$67.9K ﹤0.01% 4367
2025
Q2 		$3.21K Buy
+10,350
New +$3.49K ﹤0.01% 4065

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Cetera Investment Advisers's CGTX Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Cognition Therapeutics (CGTX) stake by 52% in Q2 2026, selling an estimated $25.2K and leaving 19,850 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4844.

Cetera Investment Advisers first reported a position in CGTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $81.2K in Q3 2025. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • Cetera Investment Advisers held 19,850 shares of Cognition Therapeutics worth $22.8K as of Q2 2026.
  • Cetera Investment Advisers sold 21,300 Cognition Therapeutics shares in Q2 2026, an estimated $25.2K.
  • Cognition Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4844 holding.
  • Cetera Investment Advisers first reported a position in Cognition Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Cetera Investment Advisers's Cognition Therapeutics position peaked at $81.2K in Q3 2025.
  • 66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.